Farmacologia Clinica ed Epidemiologia

Laboratorio di Epidemiologia Clinica dei Tumori

Pubblicazioni recenti

  • Parmelli E, Papini D, Moja L, Bandieri E, Belfiglio M, Ciccone G, De Palma R, Leoni M, Longo G, Magrini N, Moschetti I, Liberati A.
    Updating clinical recommendations for breast, colorectal and lung cancer treatments: an opportunity to improve methodology and clinical relevance.
    Ann Oncol, 22: 188-194 (2011)
    PubMed Full text
  • Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Lucisano G, Labianca R, Marchesi L, Merelli B, Robone S, Poletti P, Milesi L, Tondini C.
    Association of Socioeconomic Status With Breslow Thickness and Disease-Free and Overall Survival in Stage I-II Primary Cutaneous Melanoma.
    Mayo Clin Proc, 86: 113-119 (2011).
    PubMed Full text
  • Verderio P, Mangia A, Orlando C, Belfiglio M, Marchetti A, Bertario L, Chiappetta G, Gion M, Tonini GP, Podo F, Vocaturo A, Silvestrini R, Lombardo C, Paradiso A.
    Research trends for early cancer biomarker detection in Italy: an integrated program in oncology (PIO) survey.
    Tumori, 96: 721-725 (2010).
    PubMed Full text
  • Sichetti D, Bandieri E, Romero M, Di Biagio K, Luppi M, Belfiglio M, Tognoni G, Ripamonti CI; for ECAD Working Group.
    Impact of setting of care on pain management in patients with cancer: a multicentre cross-sectional study.
    Ann. Oncol., 21 (10): 2088-2093 (2010).
    PubMed Full text
  • Bandieri E, Sichetti D, Luppi M, Di Biagio K, Ripamonti C, Tognoni G, Belfiglio M, Romero M.
    Is pain in patients with haematological malignancies under-recognised? The results from Italian ECAD-O survey.
    Leuk Res, 34: e334-e335 (2010).
    PubMed Full text

 

Pubblicazioni significative

  • Mandalà M., Imberti G.L., Piazzalunga D., Belfiglio M., Labianca R., Barberis M., Marchesi L., Poletti P., Bonomi L., Novellino L., Di Biagio K., Milesi A., Guerra U., Tondini C.
    Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Eur. J. Cancer, 45: 2537-2545 (2009).
    PubMed Full text
  • Paradiso A., Mangia A., Orlando C., Verderio P., Belfiglio M., Marchetti A., Bertario L., Chiappetta G., Gion M., Tonini G.P., Podo F., Vocaturo A., Silvestrini R., Romani M., Belloni E., Cavallo D., Ulivi P., Tommasi S., Steffan A., Russo A., Alessio M., Calistri D., Zancan M., Parrela P., Broggini M., Giuseppe A., Buttitta F., Finocchiaro G., Mazzocco K., Veronesi G., Landuzzi L., Benevolo M., Mariani L., De Marco F., Venuti A., Giannelli G., Quaranta M., Trojano V.
    The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis.
    Int. J. Biol. Markers, 24: 119-129 (2009).
    PubMed Full text
  • De Palma R., Liberati A., Ciccone G., Bandieri E., Belfiglio M., Ceccarelli M., Leoni M., Longo G., Magrini N., Marangolo M., Roila F. Programma Ricerca e Innovazione Emilia Romagna Oncology Research Group.
    Developing clinical recommendations for breast, colorectal, and lung cancer adjuvant treatments using the GRADE system: a study from the Programma Ricerca e Innovazione Emilia Romagna Oncology Research Group.
    J. Clin. Oncol., 26: 1033-1039.
    PubMed Full text
  • Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group.
    Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial.
    Lancet Oncol. 2008 Jan;9(1):45-53.
    PubMed Full text
  • Arimidex, Tamoxifen, Alone or in Combination Trialists' Group.
    Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial.
    Lancet Oncol. 2006 Aug;7(8):633-43.
    PubMed Full text

 

ultimo aggiornamento: 23-02-2011